Concise Review: Making Stem Cells Retinal: Methods for Deriving Retinal Pigment Epithelium and Implications for Patients with Ocular Disease

Stem Cells

Volumn 33, Issue 8, 2015, Pages 2363-2373

  Leach, Lyndsay L ^a   Clegg, Dennis O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell differentiation; Embryonic stem cells; Induced pluripotent stem cells; Macular degeneration; Retinal diseases; Retinal pigment epithelium

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; EYE DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PIGMENT EPITHELIUM; PLURIPOTENT STEM CELL; RETINAL STEM CELL; STEM CELL; ANIMAL; INDUCED PLURIPOTENT STEM CELL; MACULAR DEGENERATION; METABOLISM; PATHOLOGY; RETINAL PIGMENT EPITHELIUM; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MACULAR DEGENERATION; RETINAL PIGMENT EPITHELIUM; STEM CELL TRANSPLANTATION;

EID: 84937630459     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2010     Document Type: Article

References (90)

1. Thomson JA,. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.
2. Takahashi K, Tanabe K, Ohnuki M, et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
3. Friedman DS, O'Colmain BJ, Muñoz B, et al., Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004; 122: 564-572.
4. Klein R, Chou C-F, Klein BEK, et al., Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 2011; 129: 75-80.
5. Strauss O,. The retinal pigment epithelium in visual function. Physiol Rev 2005; 85: 845-881.
6. Gehrs KM, Anderson DH, Johnson LV, et al., Age-related macular degeneration-emerging pathogenetic and therapeutic concepts. Ann Med 2006; 38: 450-471.
7. Clegg DO, Hikita ST, Hu Q, et al., Derivation of retinal pigmented epithelial cells for the treatment of ocular disease. In: Stem Cell Handbook. Stewart Sell (eds), 2nd edition. New York, NY: Springer New York; 2013: 411-418.
8. Lund RD, Wang S, Klimanskaya I, et al., Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 2006; 8: 189-199.
9. Carr A-J, Vugler AA, Hikita ST, et al., Protective effects of human iPS-derived retinal pigment epithelium cell transplantation in the retinal dystrophic rat. PLoS One 2009; 4: e8152.
10. Lu B, Malcuit C, Wang S, et al., Long-term safety and function of rpe from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells 2009; 27: 2126-2135.
11. Idelson M, Alper R, Obolensky A, et al., Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells. Cell Stem Cell 2009; 5: 396-408.
12. Schwartz SD, Hubschman J-P, Heilwell G, et al., Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 2012; 379: 713-720.
13. Schwartz SD, Regillo CD, Lam BL, et al., Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: Follow-up of two open-label phase 1/2 studies. Lancet 2014; 385: 509-516.
14. Bharti K, Rao M, Hull SC, et al., Developing cellular therapies for retinal degenerative diseases. Invest Ophthalmol Vis Sci 2014; 55: 1191-1202.
15. Cyranoski D,. Next generation stem cells cleared for human trial. Nature 2014; 10.1038/nature.2014.15897 [Epub ahead of print].
16. Buchholz DE, Hikita ST, Rowland TJ, et al., Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 2009; 27: 2427-2434.
17. Klimanskaya I, Hipp J, Rezai KA, et al., Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004; 6: 217-245.
18. Vugler A, Carr A-J, Lawrence J, et al., Elucidating the phenomenon of HESC-derived RPE: Anatomy of cell genesis, expansion and retinal transplantation. Exp Neurol 2008; 214: 347-361.
19. Carr A-J, Vugler A, Lawrence J, et al., Molecular characterization and functional analysis of phagocytosis by human embryonic stem cell-derived RPE cells using a novel human retinal assay. Mol Vis 2009; 15: 283-295.
20. Rowland TJ, Buchholz DE, Clegg DO,. Pluripotent human stem cells for the treatment of retinal disease. J Cell Physiol 2011; 227: 457-466.
21. Bharti K, Miller SS, Arnheiter H,. The new paradigm: Retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells. Pigment Cell Melanoma Res 2010; 24: 21-34.
22. Nistor G, Seiler MJ, Yan F, et al., Three-dimensional early retinal progenitor 3D tissue constructs derived from human embryonic stem cells. J Neurosci Meth 2010; 190: 63-70.
23. Osakada F, Ikeda H, Sasai Y, et al., Stepwise differentiation of pluripotent stem cells into retinal cells. Nat Protoc 2009; 4: 811-824.
24. Fuhrmann S, Zou C, Levine EM,. Retinal pigment epithelium development, plasticity, and tissue homeostasis. Exp Eye Res 2014; 123: 141-150.
25. Reynolds J, Lamba DA,. Human embryonic stem cell applications for retinal degenerations. Exp Eye res 2014; 123: 151-160.
26. Parvini M, Satarian L, Parivar K, et al., Human Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium in Retinal Treatment: From Bench to Bedside. Mol Neurobiol 2014; 50: 597-612.
27. Borooah S, Phillips MJ, Bilican B, et al., Using human induced pluripotent stem cells to treat retinal disease. Prog Retin Eye Res 2013; 37: 163-181.
28. Osakada F, Jin Z-B, Hirami Y, et al., In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci 2009; 122: 3169-3179.
29. Osakada F, Ikeda H, Mandai M, et al., Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells. Nat Biotechnol 2008; 26: 215-224.
30. Hirami Y, Osakada F, Takahashi K, et al., Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 2009; 458: 126-131.
31. Watanabe K, Kamiya D, Nishiyama A, et al., Directed differentiation of telencephalic precursors from embryonic stem cells. Nat Neurosci 2005; 8: 288-296.
32. Glinka A, Wu W, Delius H, et al., Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 1998; 391: 357-362.
33. Sakuma R, Ohnishi Yi Y-I, Meno C, et al., Inhibition of Nodal signalling by Lefty mediated through interaction with common receptors and efficient diffusion. Genes Cells 2002; 7: 401-412.
34. Kamao H, Mandai M, Okamoto S, et al., Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Reports 2014; 2: 205-218.
35. Krohne TU, Westenskow PD, Kurihara T, et al., Generation of retinal pigment epithelial cells from small molecules and OCT4 reprogrammed human induced pluripotent stem cells. Stem Cells Transl Med 2012; 1: 96-109.
36. Torrez LB, Perez Y, Yang J, et al., Derivation of neural progenitors and retinal pigment epithelium from common marmoset and human pluripotent stem cells. Stem Cells Int 2012; 2012: 417865.
37. Zhu D, Deng X, Spee C, et al., Polarized secretion of PEDF from human embryonic stem cell-derived RPE promotes retinal progenitor cell survival. Invest Ophthalmol Vis Sci 2011; 52: 1573-1585.
38. Lane A, Philip LR, Ruban L, et al., Engineering efficient retinal pigment epithelium differentiation from human pluripotent stem cells. Stem Cells Transl Med 2014; 3: 1295-1304.
39. Otonkoski T, Beattie GM, Mally MI, et al., Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells. J Clin Invest 1993; 92: 1459-1466.
40. Fuhrmann S, Levine EM, Reh TA,. Extraocular mesenchyme patterns the optic vesicle during early eye development in the embryonic chick. Development 2000; 127: 4599-4609.
41. Kokkinaki M, Sahibzada N, Golestaneh N,. Human induced pluripotent stem-derived retinal pigment epithelium (RPE) cells exhibit ion transport, membrane potential, polarized vascular endothelial growth factor secretion, and gene expression pattern similar to native RPE. Stem Cells 2011; 29: 825-835.
42. Zahabi A, Shahbazi E, Ahmadieh H, et al., A New Efficient protocol for directed differentiation of retinal pigmented epithelial cells from normal and retinal disease induced pluripotent stem cells. Stem Cells Dev 2012; 21: 2262-2272.
43. Buchholz DE, Pennington BO, Croze RH, et al., Rapid and efficient directed differentiation of human pluripotent stem cells into retinal pigmented epithelium. Stem Cells Transl Med 2013; 2: 384-393.
44. Zhu Y, Carido M, Meinhardt A, et al., Three-dimensional neuroepithelial culture from human embryonic stem cells and its use for quantitative conversion to retinal pigment epithelium. PLoS One 2013; 8: e54552.
45. Leach LL, Buchholz DE, Nadar VP, et al., Canonical/β-catenin Wnt pathway activation improves retinal pigmented epithelium derivation from human embryonic stem cells. Invest Ophthalmol Vis Sci 2015; 56: 1002-1013.
46. Nakano T, Ando S, Takata N, et al., Self-formation of optic cups and storable stratified neural retina from human ESCs. Cell Stem Cell 2012; 10: 771-785.
47. Gerrard L, Rodgers L, Cui W,. Differentiation of human embryonic stem cells to neural lineages in adherent culture by blocking bone morphogenetic protein signaling. Stem Cells 2005; 23: 1234-1241.
48. Okada Y, Shimazaki T, Sobue G, et al., Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells. Dev Biol 2004; 275: 124-142.
49. Pittack C, Grunwald GB, Reh TA,. Fibroblast growth factors are necessary for neural retina but not pigmented epithelium differentiation in chick embryos. Development 1997; 124: 805-816.
50. Perron M,. A novel function for Hedgehog signalling in retinal pigment epithelium differentiation. Development 2003; 130: 1565-1577.
51. Lamba DA, Karl MO, Ware CB, et al., Efficient generation of retinal progenitor cells from human embryonic stem cells. Proc Natl Acad Sci USA 2006; 103: 12769-12774.
52. Westenskow P, Piccolo S, Fuhrmann S,. catenin controls differentiation of the retinal pigment epithelium in the mouse optic cup by regulating Mitf and Otx2 expression. Development 2009; 136: 2505-2510.
53. Steinfeld J, Steinfeld I, Coronato N, et al., RPE specification in the chick is mediated by surface ectoderm-derived BMP and Wnt signalling. Development 2013; 140: 4959-4969.
54. Hägglund A-C, Berghard A, Carlsson L,. Canonical Wnt/β-catenin signalling is essential for optic cup formation. PLoS One 2013; 8: e81158.
55. Diniz B, Thomas P, Thomas B, et al., Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: Improved survival when implanted as a monolayer. Invest Ophthalmol Vis Sci 2013; 54: 5087-5096.
56. Meyer JS, Shearer RL, Capowski EE, et al., Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci USA 2009; 106: 16698-16703.
57. Phillips MJ, Wallace KA, Dickerson SJ, et al., Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest Ophthalmol Vis Sci 2012; 53: 2007-2019.
58. Singh R, Phillips MJ, Kuai D, et al., Functional analysis of serially expanded human iPS cell-derived RPE cultures. Invest Ophthalmol Vis Sci 2013; 54: 6767-6778.
59. Zhong X, Gutierrez C, Xue T, et al., Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat Commun 2014; 5: 4047.
60. Cho MS, Kim SJ, Ku SY, et al., Generation of retinal pigment epithelial cells from human embryonic stem cell-derived spherical neural masses. Stem Cell Res 2012; 9: 1019.
61. Maruotti J, Wahlin K, Gorrell D, et al., A simple and scalable process for the differentiation of retinal pigment epithelium from human pluripotent stem cells. Stem Cells Transl Med 2013; 2: 341-354.
62. Kuwahara A, Ozone C, Nakano T, et al., Generation of a ciliary margin-like stem cell niche from self-organizing human retinal tissue. Nat Commun 2015; 1: 1-15.
63. Reichman S, Terray A, Slembrouck A, et al., From confluent human iPS cells to self-forming neural retina and retinal pigmented epithelium. Proc Natl Acad Sci 2014; 111: 8518-8523.
64. Lee MH, Arcidiacono JA, Bilek AM, et al., Considerations for tissue-engineered and regenerative medicine product development prior to clinical trials in the United States. Tissue Eng Part B Rev 2010; 16: 41-54.
65. Au P, Hursh DA, Lim A, et al., FDA oversight of cell therapy clinical trials. Sci Transl Med 2012; 4: 149fs31.
66. Sridhar A, Steward MM, Meyer JS,. Nonxenogeneic growth and retinal differentiation of human induced pluripotent stem cells. Stem Cells Transl Med 2013; 2: 255-264.
67. Vaajasaari H, Ilmarinen T, Juuti-Uusitalo K, et al., Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells. Mol Vis 2011; 17: 558-575.
68. Pennington BO, Clegg DO, Melkoumian ZK, et al., Defined culture of human embryonic stem cells and xeno-free derivation of retinal pigmented epithelial cells on a novel, synthetic substrate. Stem Cells Transl Med 2015; 4: 165-177.
69. Grisanti S, Guidry C,. Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci 1995; 36: 391-405.
70. Bravery CA, Carmen J, Fong T, et al., Potency assay development for cellular therapy products: An ISCT. J Cytother 2013; 15: 9-19.e9.
71. Mendicino M, Bailey AM, Wonnacott K, et al., MSC-based product characterization for clinical trials: An FDA perspective. Cell Stem Cell 2014; 14: 141-145.
72. Bailey AM, Mendicino M, Au P,. An FDA perspective on preclinical development of cell-based regenerative medicine products. Nat Biotechnol 2014; 32: 721-723.
73. Gamm DM, Phillips MJ, Singh R,. Modeling retinal degenerative diseases with human iPS-derived cells: Current status and future implications. Exp Rev Ophthalmol 2013; 8: 213-216.
74. Phelan JK, Bok D,. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Mol Vis 2000; 6: 116-124.
75. Jayasundera T, Branham KEH, Othman M, et al., RP2 phenotype and pathogenetic correlations in X-linked retinitis pigmentosa. Arch Ophthalmol 2010; 128: 915-923.
76. Schwarz N, Carr A-J, Lane A, et al., Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells. Hum Mol Genet 2015; 24: 972-986.
77. Evans RJ, Schwarz N, Nagel-Wolfrum K, et al., The retinitis pigmentosa protein RP2 links pericentriolar vesicle transport between the Golgi and the primary cilium. Hum Mol Genet 2010; 19: 1358-1367.
78. Li Y, Wu W-H, Hsu C-W, et al., Gene Therapy in patient-specific stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein defects. Mol Ther 2014; 22: 1688-1697.
79. Seabra MC, Brown MS, Slaughter CA, et al., Purification of component A of Rab geranylgeranyl transferase: Possible identity with the choroideremia gene product. Cell 1992; 70: 1049-1057.
80. Cereso N, Pequignot MO, Robert L, et al., Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient. Mol Ther Method Clin Dev 2014; 1: 14011.
81. Maguire AM, Simonelli F, Pierce EA, et al., Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 2008; 358: 2240-2248.
82. Singh R, Shen W, Kuai D, et al., iPS cell modeling of best disease: Insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet 2013; 22: 593-607.
83. Meyer JS, Howden SE, Wallace KA, et al., Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells 2011; 29: 1206-1218.
84. Polinati P, Ilmarinen T, Trokovic R, et al., Patient specific induced pluripotent stem cells derived RPE cells: Understanding the pathogenesis of retinopathy in LCHAD deficiency. Invest Ophthalmol Vis Sci 2014. doi: 10.1167/iovs.14-14007 [Epub ahead of print].
85. Hayasaka S, Saito T, Nakajima H, et al., Gyrate atrophy with hyperornithinaemia: Different types of responsiveness to vitamin B6. Br J Ophthalmol 1981; 65: 478-483.
86. Kennaway NG, Weleber RG, Buist NR,. Gyrate atrophy of the choroid and retina with hyperornithinemia: Biochemical and histologic studies and response to vitamin B6. Am J Hum Genet 1980; 32: 529-541.
87. Beatty S, Koh H, Phil M, et al., The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000; 45: 115-134.
88. Ambati J, Atkinson JP, Gelfand BD,. Immunology of age-related macular degeneration. Nat Rev Immunol 2013; 13: 438-451.
89. Yang J, Li Y, Chan L, et al., Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines. Hum Mol Genet 2014; 23: 3445-3455.
90. Phillips MJ, Perez ET, Martin JM, et al., Modeling human retinal development with patient-specific iPS cells reveals multiple roles for VSX2. Stem Cells 2014; 32: 1480-1492.